Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Eckardt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Der Radiologe|February 28, 2014
[Prostate cancer]T Franiel, N Eckardt, M Waginger, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 1, 1990
Occurrence of human papillomavirus DNA types 16 and 18 (HPV-16/18) in cervical smears as compared to cytological findingsH G Köchel, A Teichmann, N Eckardt, et al.
International Journal of Legal Medicine|December 17, 2022
Delayed occurrence of traumatic aortic dissection? Biomechanical considerations and literatureH Muggenthaler, D Bismann, N Eckardt, et al.
Infusionstherapie Und Transfusionsmedizin|February 1, 1992
[Prevalence of hepatitis C virus in poly-transfused patients with hematologic and oncologic diseases]K Gutensohn, B Knödler, W Zeller, et al.
Innere Medizin (Heidelberg, Germany)|October 4, 2022
[Refractory thrombotic thrombocytopenic purpura]K Herfurth, J Ruhe, K Kentouche, et al.
Infection|May 19, 2025
A very rare case of osseous involvement of the dens axis in a 52-year-old HIV positive patient as part of secondary syphilisK Lange, C Helbig, N Eckardt, et al.
British Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Der Radiologe|February 28, 2014
[Prostate cancer]T Franiel, N Eckardt, M Waginger, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 1, 1990
Occurrence of human papillomavirus DNA types 16 and 18 (HPV-16/18) in cervical smears as compared to cytological findingsH G Köchel, A Teichmann, N Eckardt, et al.
International Journal of Legal Medicine|December 17, 2022
Delayed occurrence of traumatic aortic dissection? Biomechanical considerations and literatureH Muggenthaler, D Bismann, N Eckardt, et al.
Infusionstherapie Und Transfusionsmedizin|February 1, 1992
[Prevalence of hepatitis C virus in poly-transfused patients with hematologic and oncologic diseases]K Gutensohn, B Knödler, W Zeller, et al.
Innere Medizin (Heidelberg, Germany)|October 4, 2022
[Refractory thrombotic thrombocytopenic purpura]K Herfurth, J Ruhe, K Kentouche, et al.
Infection|May 19, 2025
A very rare case of osseous involvement of the dens axis in a 52-year-old HIV positive patient as part of secondary syphilisK Lange, C Helbig, N Eckardt, et al.
British Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Pageof 1